MX9700658A - Process for folding of proteins like recombinant hirudin or epidermal growth factor. - Google Patents

Process for folding of proteins like recombinant hirudin or epidermal growth factor.

Info

Publication number
MX9700658A
MX9700658A MX9700658A MX9700658A MX9700658A MX 9700658 A MX9700658 A MX 9700658A MX 9700658 A MX9700658 A MX 9700658A MX 9700658 A MX9700658 A MX 9700658A MX 9700658 A MX9700658 A MX 9700658A
Authority
MX
Mexico
Prior art keywords
growth factor
epidermal growth
proteins
folding
recombinant hirudin
Prior art date
Application number
MX9700658A
Other languages
Spanish (es)
Other versions
MXPA97000658A (en
Inventor
Jui Yoa Chang
Original Assignee
Novartis Ag Tambien Denominada
Y O Novartis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag Tambien Denominada, Y O Novartis Inc filed Critical Novartis Ag Tambien Denominada
Priority claimed from PCT/EP1995/002720 external-priority patent/WO1996003425A1/en
Publication of MXPA97000658A publication Critical patent/MXPA97000658A/en
Publication of MX9700658A publication Critical patent/MX9700658A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to a process for the preparation of a biologically active and correctly folded protein in the presence of a denaturing agent like urea or guanidine hydrochloride and the separation of the correctly folded protein therefrom directly. This process can be applied, for example, in the renaturation of recombinant proteins like hirudin or epidermal growth factor.
MX9700658A 1995-07-12 1995-07-12 Process for folding of proteins like recombinant hirudin or epidermal growth factor. MX9700658A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94810437.7 1994-07-25
PCT/EP1995/002720 WO1996003425A1 (en) 1994-07-25 1995-07-12 Process for folding of proteins like recombinant hirudin or epidermal growth factor

Publications (2)

Publication Number Publication Date
MXPA97000658A MXPA97000658A (en) 1998-01-01
MX9700658A true MX9700658A (en) 1998-01-31

Family

ID=39165440

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700658A MX9700658A (en) 1995-07-12 1995-07-12 Process for folding of proteins like recombinant hirudin or epidermal growth factor.

Country Status (1)

Country Link
MX (1) MX9700658A (en)

Similar Documents

Publication Publication Date Title
AU9174398A (en) Peptides
IL92012A0 (en) Process for the activation of gene-technologically produced proteins expressed in prokaryotes
TR199900666T2 (en) Antibody to human parathormone-related peptides.
UA43348C2 (en) Aqueous pharmaceutical composition, which includes the factor of the nerve growth factor (variants) and liophilic pharmaceutical composition
DE69534778D1 (en) Cathepsin-02-protease
IL114702A0 (en) Process for the production of biologically active protein
EP0875567A3 (en) Mycbinding Zinc-finger proteins, preparation and use thereof
BG101295A (en) Modified human c3 proteins
AU3257197A (en) Process for the activation of denatured protein
EP0695801A3 (en) Yeast protein derived peptide compositions, a process for preparing them and their use
DE69619982D1 (en) STABILIZED STANDARDS AND CALIBRATORS
WO1997028104A3 (en) Buffer systems for use in stabilizing pharmaceutical preparations
MX9700658A (en) Process for folding of proteins like recombinant hirudin or epidermal growth factor.
DE3687995D1 (en) METHOD FOR PURIFYING INTERFERON AND COMPOSITION MADE THEREOF.
NO970081L (en) Method of folding proteins such as recombinant hirudin or epidermal growth factor
WO2000049038A3 (en) Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
WO2002073373A3 (en) Ensemble-based strategy for the design of protein pharmaceuticals
WO2004089973A3 (en) Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
CA2163805A1 (en) Novel activating factor of leukocytes
AU1477295A (en) Use of azoles as virucidal agents in solutions of biologically active proteins
PL355852A1 (en) Fragments of virus protein vp2 or 3 of the polyoma virus, used for transporting active ingredients
WO1997041207A3 (en) Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector
DE59509948D1 (en) CONJUGATE OF AN ACTIVE INGREDIENT AND A NATURAL PROTEIN NOT CONSIDERED AS NON-BODY
Vendruscolo Folding, Stability and Design of Proteins
WO2001042423A3 (en) Compositions and methods for detecting stress-inducible proteins